mycobacterium
tuberculosi
acidfast
bacillu
caus
pulmonari
extrapulmonari
tuberculosi
communic
infecti
diseas
high
morbid
mortal
remain
major
public
health
burden
worldwid
accord
world
health
organ
global
report
tuberculosi
one
top
caus
death
worldwid
rank
acquir
immun
defici
syndrom
estim
million
newli
diagnos
tuberculosi
case
one
concern
issu
face
physician
tuberculosisendem
area
difficulti
discrimin
pulmonari
tuberculosi
ptb
communityacquir
pneumonia
cap
caus
nonmycobacteri
clinic
featur
ptb
nonspecif
similar
cap
mani
diagnost
sensit
microscop
examin
diagnos
tuberculosi
difficult
accur
discrimin
ptb
cap
earli
stage
diagnost
process
particularli
manag
patient
mild
symptom
moreov
initi
inappropri
antibiot
therapi
ptb
particularli
newer
fluoroquinolon
commonli
prescrib
cap
may
delay
diagnosi
ptb
associ
poor
prognosi
drugresist
thu
identifi
marker
discrimin
ptb
cap
earli
import
howev
insuffici
data
avail
despit
fact
studi
suggest
sever
marker
creactiv
protein
crp
procalcitonin
solubl
trigger
receptor
neutrophillymphocyt
ratio
discriminatori
delta
neutrophil
index
dni
develop
measur
fraction
immatur
granulocyt
reliabl
rapidli
use
automat
hematolog
analyz
siemen
healthcar
diagnost
myeloperoxidas
mpo
nuclear
lobular
data
shown
dni
could
use
distinguish
bacteri
viral
kidney
reject
cap
upper
respiratori
howev
data
avail
regard
clinic
use
dni
discrimin
ptb
cap
therefor
studi
compar
initi
dni
level
patient
ptb
cap
evalu
well
dni
valu
predict
ptb
compar
commonli
use
inflammatori
blood
marker
retrospect
review
medic
record
consecut
adult
patient
admit
respiratori
diseas
novemb
decemb
hallym
univers
kangnam
sacr
heart
hospit
seoul
south
korea
total
case
ptb
cap
identifi
intens
care
unit
admiss
case
due
sever
respiratori
failur
shock
n
refer
case
alreadi
receiv
therapi
n
readmiss
case
n
exclud
final
patient
ptb
n
cap
n
admit
gener
ward
includ
analysi
institut
review
board
hallym
univers
kangnam
sacr
heart
hospit
approv
studi
permit
review
public
patient
record
requir
inform
consent
individu
patient
waiv
due
retrospect
design
studi
diagnosi
ptb
consid
definit
microbiolog
examin
acidfast
bacillu
stain
polymeras
chain
reaction
acidfast
bacillu
cultur
use
respiratori
tract
specimen
confirm
infect
patient
clinic
present
met
criteria
clinic
activ
ptb
establish
world
health
organ
microbiolog
test
tuberculosi
tuberculosi
pleurisi
defin
lymphocyt
exud
pleural
fluid
adenosin
deaminas
level
ul
clinic
improv
observ
antituberculosi
treatment
cap
defin
presenc
new
infiltr
chest
radiographi
without
evid
ptb
plu
least
one
follow
respiratori
symptom
includ
cough
sputum
dyspnea
pleurit
chest
pain
fever
bodi
temperatur
hypothermia
bodi
temperatur
abnorm
breath
sound
dni
valu
automat
calcul
cell
analyz
previou
studi
dni
valu
measur
peripher
blood
use
automat
cell
analyz
advia
hematolog
system
siemen
healthcar
diagnost
forchheim
germani
red
blood
cell
lysi
cell
size
stain
intens
measur
tungstenhalogenbas
optic
system
mpo
channel
count
differenti
granulocyt
lymphocyt
monocyt
base
size
mpo
content
follow
cell
count
classif
accord
size
lobular
nuclear
densiti
use
laser
diodebas
optic
system
lobular
nuclear
densiti
channel
count
dni
valu
calcul
follow
formula
present
percentag
dni
neutrophil
eosinophil
subfract
measur
mpo
channel
cytochem
mpo
reaction
polymorphonuclear
neutrophil
subfract
measur
nuclear
lobular
channel
reflect
light
beam
microbiolog
etiolog
patient
suspect
ptb
cap
evalu
peripher
blood
sputum
bronchoalveolar
fluid
nasopharyng
oropharyng
specimen
pleural
fluid
use
follow
test
microbiolog
cultur
bacteria
multiplex
realtim
polymeras
chain
reaction
pcr
test
bacteri
agent
includ
streptococcu
pneumonia
haemophilu
influenza
mycoplasma
pneumonia
chlamydia
pneumonia
etc
multiplex
realtim
pcr
common
respiratori
virus
urinari
antigen
test
streptococcu
pneumonia
legionella
pneumophila
dni
valu
routin
includ
complet
blood
count
test
institut
thu
initi
dni
valu
start
treatment
ptb
cap
avail
patient
data
clinic
characterist
includ
age
gender
smoke
histori
underli
diseas
laboratori
examin
includ
dni
white
blood
cell
wbc
count
creactiv
protein
crp
radiograph
find
time
initi
admiss
collect
anonym
data
categor
variabl
present
number
percentag
data
continu
variabl
present
median
interquartil
rang
iqr
data
compar
use
chisquar
fisher
exact
test
categor
variabl
u
test
continu
variabl
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
dni
diagnos
ptb
calcul
use
standard
definit
predict
valu
inflammatori
marker
includ
dni
ptb
evalu
receiv
oper
characterist
roc
curv
analysi
area
curv
auc
also
calcul
multivari
analys
logist
regress
perform
identifi
factor
predict
ptb
statist
analys
perform
use
pasw
softwar
ver
spss
inc
chicago
il
usa
twosid
pvalu
consid
indic
statist
signific
institut
review
board
hallym
univers
kangnam
sacr
heart
hospit
approv
studi
permit
review
public
patient
record
total
patient
ptb
patient
cap
includ
analysi
nonimmunocompromis
base
neg
human
immunodefici
viru
infect
test
result
clinic
characterist
ptb
patient
cap
patient
summar
tabl
median
age
year
iqr
year
year
iqr
year
patient
ptb
cap
respect
half
patient
male
group
rate
never
smoker
higher
cap
group
p
differ
age
gender
underli
pulmonari
extrapulmonari
diseas
observ
among
two
group
except
histori
ptb
treatment
ptb
group
vs
cap
group
p
patient
respiratori
symptom
sign
rate
cough
p
sputum
p
fever
p
significantli
higher
cap
group
hemoptysi
p
frequent
observ
ptb
group
signific
differ
rate
dyspnea
sever
diseas
pneumonia
sever
index
class
iii
observ
among
two
group
twentyseven
patient
ptb
posit
result
sputum
acidfast
bacillu
stain
test
compar
initi
laboratori
find
includ
wbc
dni
crp
level
patient
ptb
cap
tabl
patient
ptb
median
wbc
count
dni
crp
iqr
iqr
mgl
iqr
mgl
respect
significantli
lower
patient
cap
p
wbc
dni
crp
valu
initi
dni
valu
patient
ptb
rang
patient
ptb
initi
dni
valu
contrast
initi
dni
valu
patient
cap
rang
significantli
higher
patient
ptb
patient
cap
initi
dni
valu
fig
nonmycobacteri
agent
viral
agent
identifi
patient
cap
respect
significantli
higher
isol
rate
compar
patient
ptb
howev
patient
ptb
coinfect
nonmycobacteri
agent
pneumonia
h
influenza
three
ptb
patient
viral
etiolog
rhinoviru
influenza
viru
perform
roc
curv
analysi
inflammatori
marker
includ
wbc
dni
crp
diagnos
ptb
fig
discriminatori
power
dni
diagnos
ptb
high
sensit
specif
dni
cutoff
auc
confid
interv
ci
sensit
specif
dni
cutoff
auc
ci
higher
wbc
crp
overal
diagnost
sensit
specif
ppv
npv
ptb
dni
cutoff
respect
dni
cutoff
respect
initi
chest
radiographi
imag
avail
patient
domin
pattern
main
lobe
involv
differ
patient
ptb
cap
tabl
patient
ptb
n
nodul
without
linear
opac
half
n
patient
upper
lobe
involv
contrast
n
patient
cap
consolid
n
consolid
ground
glass
opac
patient
n
lower
lobe
involv
without
upper
lobe
involv
also
perform
univari
multivari
analys
logist
regress
model
determin
factor
associ
predict
ptb
tabl
variabl
use
ex
current
smoker
n
fever
n
upper
lobe
involv
n
dni
n
fever
odd
ratio
p
upper
lobe
involv
p
dni
p
significantli
associ
predict
ptb
import
find
studi
initi
dni
valu
significantli
lower
patient
ptb
compar
patient
cap
discriminatori
power
dni
diagnos
ptb
higher
commonli
use
inflammatori
blood
marker
wbc
crp
suggest
util
dni
discrimin
ptb
cap
moreov
given
rel
high
sensit
npv
diagnos
ptb
dni
cutoff
initi
dni
valu
may
use
rule
possibl
ptb
suspect
patient
dni
valu
identifi
ptb
troublesom
clinic
problem
tuberculosisendem
area
failur
discrimin
ptb
cap
may
result
consider
public
health
econom
burden
thu
effort
made
distinguish
ptb
respiratori
diseas
exampl
liam
et
al
report
clinic
featur
patient
ptb
distinguish
patient
cap
show
longer
durat
symptom
week
night
sweat
upper
lobe
involv
caviti
radiographi
lower
wbc
count
predict
ugajin
et
al
report
serum
procalcitonin
significantli
lower
patient
ptb
patient
cap
studi
includ
patient
ptb
patient
cap
healthi
kang
et
al
also
found
serum
procalcitonin
crp
level
lower
patient
ptb
patient
recent
new
biomark
trigger
receptor
express
myeloid
cell
trem
evalu
sputum
patient
ptb
cap
discrimin
diseas
trem
novel
activ
receptor
ig
superfamili
express
human
myeloid
cell
express
upregul
extracellular
bacteria
fungi
weak
mycobacteri
viral
intracellular
bacteri
noninfecti
inflammatori
solubl
form
receptor
measur
plasma
bodi
fluid
pleural
periton
fluid
may
differenti
infecti
noninfecti
caus
howev
protein
upregul
sputum
among
patient
cap
ptb
help
differenti
two
date
suffici
data
avail
accur
easili
applic
marker
data
exist
util
dni
valu
given
dni
conveni
test
provid
reliabl
data
rapidli
routin
blood
test
consider
discrimin
power
even
adjust
clinic
paramet
multivari
analysi
dni
may
import
supplementari
role
diagnost
exclus
ptb
cap
result
partli
explain
observ
tuberculosi
rel
chronic
inflammatori
process
associ
delay
onset
adapt
immun
granuloma
format
seri
complex
interact
host
thu
proport
immatur
granulocyt
could
rel
lower
mycobacteri
infect
bacteri
viral
infect
cap
actual
three
ptb
patient
bacteri
coinfect
rel
higher
dni
level
studi
support
hypothesi
similar
find
recent
studi
valid
dni
variou
clinic
scenario
also
demonstr
differ
dni
level
bacteri
viral
infect
infecti
pyelonephr
versu
organ
reject
howev
lack
data
regard
dni
level
among
nontuberculosi
patient
ptb
cap
context
find
could
clinic
signific
although
inflammatori
respons
remain
specul
may
partli
help
understand
pathophysiolog
ptb
infect
studi
sever
limit
first
includ
patient
ptb
cap
compar
two
group
retrospect
studi
design
thu
prospect
studi
includ
variou
respiratori
diseas
need
accur
evalu
clinic
applic
dni
discrimin
ptb
second
exclud
sever
case
requir
intens
care
unit
admiss
due
sever
respiratori
failur
shock
howev
case
admit
intens
care
unit
cap
extrem
high
dni
valu
case
ptb
clinic
instabl
actual
clinic
practic
exclud
sever
case
final
studi
popul
rel
small
studi
conduct
singl
center
rel
short
studi
period
thu
believ
find
testifi
valid
set
conclus
show
initi
dni
valu
lower
patient
ptb
cap
initi
elev
dni
valu
may
use
rule
possibl
ptb
due
high
npv
